Analyst consensus rating
PMV Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
PMV Pharmaceuticals's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked November 14, 2026.
Get free PMV Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.27
- Average price target
- $4.00
- High price target
- $5.00
- Low price target
- $3.00
- Low target gap
- +136.2%
- Target upside
- +215%
- High target gap
- +293.7%
- Target range width
- 157.5%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for PMV Pharmaceuticals?
PMV Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $4.00.
How far are PMV Pharmaceuticals's low and high targets from the recorded price?
The low target implies +136.2%, while the high target implies +293.7%.
How many analysts are included in PMV Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is PMV Pharmaceuticals's target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $1.27, then one is subtracted to produce +215%. This does not guarantee a future return.
When was PMV Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.